多发性硬化症中身体活动的神经认知相关性:元认知和认知灵活性
Emine İpek Halatcı1, Hilal Aslan2, Aybike Erkoç3
1Vocational School of Health Services, Department of Therapy and Rehabilitation, Disabled Care and Rehabilitation Program, Ankara Yıldırım Beyazıt University, No. 35, Yıldırım Beyazıt, Ankara, Turkey. emineipekhalatci@aybu.edu.tr.
Acta neurologica Belgica
|August 5, 2025
概括
与健康个体相比,患有多发性硬化症 (MS) 的人表现出较低的体力活动 (PA) 和认知灵活性,以及注意力和元认知能力受损. 这些发现凸显了在MS康复计划中需要进行全面评估的必要性.
科学领域:
- 神经学 神经学
- 康复科学 康复科学 康复科学
- 认知神经科学 认知神经科学
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经疾病,影响身体和认知功能.
- 了解MS中身体活动 (PA) 和认知领域之间的相互作用对于有效的管理至关重要.
- 识别特定的功能缺陷有助于为患有多发性硬化症的人制定有针对性的干预策略.
研究的目的:
- 为了比较MS患者和健康对照者之间的身体活动 (PA) 水平,认知灵活性,超认知和注意力.
- 为了研究PA水平和认知灵活性,元认知和MS患者的注意力之间的关系.
- 确定与MS相关的功能缺陷,以改善干预计划的开发.
主要方法:
- 一项涉及35名复发性复发性多发性硬化症患者和33名健康对照者的横截面研究.
- 评估PA (IPAQ),认知灵活性 (CFI),元认知 (MCS-30) 和注意力 (Stroop测试,跟踪测试).
- 统计分析以比较群体并检查多发性硬化组中PA和认知指标之间的相关性.
主要成果:
- 与对照人群相比,MS患者的PA水平 (IPAQ) 和认知灵活性 (CFI) 显著降低.
- 多发性硬化症的参与者表现出更高的元认知分数 (MCS-30) 和更长的注意力测试 (STT,TMT) 完成时间.
- 在MS组中,在Stroop测试的特定部分的PA水平和表现之间发现了显著的负相关性.
结论:
- 身体活动,认知灵活性,元认知和注意力都会对患有多发性硬化症的人产生负面影响.
- 常规评估应包括在MS患者中详细评估PA水平和认知功能.
- 这些全面的评估对于MS患者有效的康复规划至关重要.
相关概念视频
01:26Metacognition
281
Metacognition is a conscious process where individuals are aware of their cognitive and executive processes, such as planning before solving a problem or self-monitoring during reading. For instance, a writer may need help with composing a piece. The situation involves a writer who is working on a piece of writing, but while doing so, they realize that something is missing. They notice that their characters lack depth or details. This realization occurs because the writer is reflecting on their...
281
01:30Cognitive Development During Adulthood
279
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
279
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206